Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.13.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDK.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDK.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDK.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.4.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.4.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.4.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.26NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.26NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.37NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.37NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JQ.2.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JQ.2.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JQ.2.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.23.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.23.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.23.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DY.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DY.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DY.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.2.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LJ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LJ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LE.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LE.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LE.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
MD.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
MD.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MD.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.5.1.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.5.1.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LE.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LE.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LE.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDQNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDQNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDQNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.502NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.502NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.502NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.285NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used